Ka-hortagga SARS-CoV-2 Qalabka Tijaabada Kahortagga Jirka Dhexdhexaadinta (ELISA)
Mabda'a
Qalabku wuxuu adeegsadaa mabda'a qiimeynta tartanka si loo ogaado ka-hortagga unugyada difaaca jirka ee SARS-CoV-2 ee serum ama muunadaha balaasmaha.Marka hore, muunadda la tijaabinayo, xakamaynta togan, iyo xakamaynta taban ayaa lagu qasi karaa HRP-RBD si ay antibody-ka dhexdhexaadka ah ugu xidho HRP-RBD, ka dibna isku dar ah ayaa lagu daraa saxan qabashada oo horay loogu dahaadhay borotiinka hACE2.HRP-RBD kuma xidhna ka takhalusida antibody iyo sidoo kale HRP-RBD kasta oo ku xidhan antibody aan dhexdhexaad ahayn waxaa lagu qaban doonaa saxan dahaarka ah, halka HRP-RBD adag oo ku xidhan dhexdhexaadinta antibody la saaro inta lagu jiro dhaqidda.Xalka TMB ayaa markaa lagu daray si uu midab u yeesho.Ugu dambeyntii, xal joojinta ayaa lagu daray oo falcelinta waa la joojiyay.Joogitaanka ama maqnaanshaha Anti-SARS-CoV-2 ka-hortagga kahortaga difaaca ee muunada waxaa lagu qiimeeyay nuugista (A-qiimaha) akhristaha microplate.
Tilmaamaha Alaabta
Dareen sare, gaar ahaan iyo xasilooni
Tilmaamaha Alaabta
| Mabda'a | Baaritaanka difaaca jirka ee Enzyme ayaa ku xiran |
| Nooca | Habka tartanka |
| Shahaado | CE |
| Tijaabada | Serum / plasma |
| Tilmaamid | 96T |
| Heerkulka kaydinta | 2-8℃ |
| Nolosha shelf | 12 bilood |
Dalbashada Macluumaadka
| Magaca alaabta | Xirmo | Tijaabada |
| Ka-hortagga SARS-CoV-2 Qalabka Tijaabada Kahortagga Jirka Dhexdhexaadinta (ELISA) | 96T | Serum / plasma |
